Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
The right decision should be based on your diagnosis, your goals, and the best evidence available today rather than assumptions, marketing claims, or anecdotal experiences found online
Rajman et al., 2018
Infliximab for pediatric patients with ulcerative colitis: a phase 3, open-label, uncontrolled, multicenter trial in Japan
For most private plans, coverage of new generics typically follows shortly after they become commercially available
US$ 24.29
US$ 28.06
US$ 24.03
US$ 21.60
US$ 24.38
